Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study: A Randomized, Double-Blind Study of Simvastatin, Fenofibrate, and Combined Fenofibrate and Simvastatin in Patients With Controlled Type II Diabetics Without Evidence of Coronary Disease.
Phase of Trial: Phase III
Latest Information Update: 13 Oct 2009
At a glance
- Drugs Fenofibrate (Primary) ; Simvastatin (Primary)
- Indications Dyslipidaemias; Lipid metabolism disorders
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms DIACOR
- 21 Nov 2006 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History